Roche Holding AG (RHHBY)
32.81
+0.16
(+0.49%)
USD |
OTCM |
May 17, 16:00
Roche Price: 32.81 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 32.56 | 32.99 | 32.44 | 32.81 | 2.559M |
| May 16, 2024 | 32.52 | 32.78 | 32.40 | 32.65 | 5.299M |
| May 15, 2024 | 31.29 | 31.53 | 31.24 | 31.40 | 1.187M |
| May 14, 2024 | 30.73 | 31.05 | 30.68 | 30.95 | 2.502M |
| May 13, 2024 | 31.26 | 31.47 | 30.06 | 30.35 | 5.421M |
| May 10, 2024 | 30.95 | 31.11 | 30.91 | 30.95 | 1.519M |
| May 09, 2024 | 30.42 | 30.92 | 30.40 | 30.90 | 1.264M |
| May 08, 2024 | 30.48 | 30.61 | 30.42 | 30.42 | 1.807M |
| May 07, 2024 | 30.32 | 30.52 | 30.31 | 30.48 | 1.122M |
| May 06, 2024 | 30.16 | 30.23 | 30.03 | 30.09 | 2.163M |
| May 03, 2024 | 30.04 | 30.08 | 29.72 | 29.83 | 4.829M |
| May 02, 2024 | 29.71 | 29.73 | 29.20 | 29.26 | 6.646M |
| May 01, 2024 | 29.80 | 30.05 | 29.53 | 29.75 | 5.435M |
| Apr 30, 2024 | 29.92 | 30.15 | 29.81 | 29.82 | 3.381M |
| Apr 29, 2024 | 30.42 | 30.48 | 30.27 | 30.33 | 1.944M |
| Apr 26, 2024 | 30.10 | 30.28 | 30.07 | 30.25 | 2.834M |
| Apr 25, 2024 | 30.08 | 30.16 | 29.80 | 30.02 | 3.931M |
| Apr 24, 2024 | 30.39 | 30.57 | 30.15 | 30.54 | 3.144M |
| Apr 23, 2024 | 31.47 | 31.59 | 31.23 | 31.24 | 1.503M |
| Apr 22, 2024 | 30.84 | 31.13 | 30.83 | 30.91 | 2.093M |
| Apr 19, 2024 | 30.20 | 30.50 | 30.20 | 30.41 | 18.59M |
| Apr 18, 2024 | 30.17 | 30.19 | 29.95 | 30.05 | 2.078M |
| Apr 17, 2024 | 30.37 | 30.37 | 30.08 | 30.08 | 5.044M |
| Apr 16, 2024 | 30.31 | 30.34 | 30.15 | 30.23 | 2.181M |
| Apr 15, 2024 | 30.73 | 30.82 | 30.50 | 30.58 | 4.637M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
29.26
Minimum
May 02 2024
53.44
Maximum
Apr 08 2022
40.82
Average
40.98
Median
Nov 24 2020
Price Benchmarks
| Novartis AG | 102.57 |
| Pfizer Inc | 28.64 |
| ADC Therapeutics SA | 4.125 |
| Lonza Group Ltd | 58.09 |
| Sarepta Therapeutics Inc | 131.38 |
Price Related Metrics
| PE Ratio | 16.40 |
| PS Ratio | 3.116 |
| Price to Book Value | 5.996 |
| Price to Free Cash Flow | 16.46 |
| Earnings Yield | 6.10% |
| Market Cap | 209.26B |
| Operating PE Ratio | 12.26 |
| Normalized PE Ratio | 16.21 |